Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Blueprint Medicines Corp (NQ: BPMC)
96.77 USD  -1.03 (-1.05%)
Official Closing Price  /  Updated: 5:00 PM EDT, Jun 19, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 791,100
Open 97.99
Bid (Size) 92.89 (1)
Ask (Size) 99.99 (1)
Prev. Close 97.80
Today's Range 95.54 - 98.94
52wk Range 44.58 - 100.76
Shares Outstanding 43,837,337
Dividend Yield N/A
Performance
YTD
+89.08%
+89.08%
1 Month
+27.53%
+27.53%
3 Month
+16.07%
+16.07%
6 Month
+86.28%
+86.28%
1 Year
+39.10%
+39.10%
Top News
More News
Blueprint Medicines Presents Updated EXPLORER Trial Data for Avapritinib in Patients with Systemic Mastocytosis at 24th EHA Congress
-- Confirmed 77% ORR per central review in advanced SM -- Read More
from PR Newswire
Blueprint Medicines Submits New Drug Application to U.S. Food and Drug Administration for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced it has submitted a New Drug... Read More
from PR Newswire
More News
Read More
Blueprint Medicines' Highly Selective RET Inhibitor BLU-667 Shows Durable Anti-Tumor Activity in Patients with RET-Altered Cancers in Updated ARROW Trial Data Presented at ASCO 2019
from PR Newswire
Blueprint Medicines Presents NAVIGATOR Trial Data in PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST at ASCO 2019 Supporting Planned Marketing Applications for Avapritinib
from PR Newswire
Blueprint Medicines to Present at Upcoming Investor Conferences in June
from PR Newswire
Shares of cancer-therapy companies skyrocket after Pfizer acquisition news
category TPTX , BPMC , MRTX , and 19 more.
from MarketWatch
Blueprint Medici Trading Higher Today on Above-Average Volume (BPMC)
from Comtex SmarTrend® News Briefs
Noteworthy Monday Option Activity: GWRE, GLYC, BPMC
category Stocks
from Market News Video
Stocks With Rising Relative Price Strength: Blueprint Medicines
from Investor's Business Daily
Blueprint Medicines Shows Rising Price Performance With Jump To 95 RS Rating
from Investor's Business Daily
Shares of Blueprint Medici Down on Above Average Volume, Moving Against Trend (BPMC)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.